Exult Healthcare

A release from UCLA notes that Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them. In addition, the number of people with depression has increased 18 percent since 2005, according to the World Health Organization, which this year launched a global campaign encouraging people to seek treatment.

TMS has been approved by the FDA for treating depression that doesn’t respond to medications. UCLA researchers say it has been underused, but new equipment being rolled out this summer promises to make the treatment available to more people.

The release quotes Dr. Ian Cook, director of the UCLA Depression Research and Clinic Program, as saying, “We are actually changing how the brain circuits are arranged, how they talk to each other. The brain is an amazingly changeable organ. In fact, every time people learn something new, there are physical changes in the brain structure that can be detected.”

Want to schedule an appointment?

Contact ExultHealthcare @ Our Sherman Location (903) 361-5066 Located @ 600 E Taylor Street Sherman TX 75090

We also provide TMS services at out McKinney location at 4801 Medical Center Dr. TX 75069. Call (972) 369-4220 to schedule an appointment here

http://thirdage.com/magnetic-stimulation-to-rewire-the-brain-for-people-with-depression/

Magnetic Stimulation to “Rewire” the Brain for People with Depression Using musical cues to learn a physical task significantly develops an important part of the brain, according to a study published in July 2017 in the journal Brain & Cognition. … Read More→

We all need encouragement from time to time. Hear from other people just like you, as they explain their experience with depression and how TMS has helped them regain control of their life.
https://youtu.be/M-u5XxpUcTw

Sherry's Story of Depression The results discussed in this testimonial may not be consistent with Clinical Trial results. In a controlled clinical trial, patients treated with active Neu...